Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0K5EI
|
||||
Former ID |
DNC009010
|
||||
Drug Name |
Naphthalen-2-yl cyclohexylcarbamate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529791] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H19NO2
|
||||
Canonical SMILES |
C1CCC(CC1)NC(=O)OC2=CC3=CC=CC=C3C=C2
|
||||
InChI |
1S/C17H19NO2/c19-17(18-15-8-2-1-3-9-15)20-16-11-10-13-6-4-5-7-14(13)12-16/h4-7,10-12,15H,1-3,8-9H2,(H,18,19)
|
||||
InChIKey |
ZYHUWMGJJOBBCF-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529791] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.